FSCSX vs. FBIOX

In the year-to-date period, FSCSX achieves a -3.76% return, which is significantly higher than FBIOX's -9.60% return. Over the past 10 years, FSCSX has outperformed FBIOX with an annualized return of 8.71%, while FBIOX has yielded a comparatively lower -3.24% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

FSCSX has a 0.67% expense ratio, which is lower than FBIOX's 0.69% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Software & IT Services Portfolio (FSCSX) and Fidelity Select Biotechnology Portfolio (FBIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FSCSX Sharpe Ratio is -0.05, which is higher than the FBIOX Sharpe Ratio of -0.26. The chart below compares the historical Sharpe Ratios of FSCSX and FBIOX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FSCSX's dividend yield for the trailing twelve months is around 1.62%, more than FBIOX's 1.34% yield.

The maximum FSCSX drawdown since its inception was -58.41%, smaller than the maximum FBIOX drawdown of -71.96%. Use the drawdown chart below to compare losses from any high point for FSCSX and FBIOX. For additional features, visit the drawdowns tool.

The current volatility for Fidelity Select Software & IT Services Portfolio (FSCSX) is 8.91%, while Fidelity Select Biotechnology Portfolio (FBIOX) has a volatility of 10.99%. This indicates that FSCSX experiences smaller price fluctuations and is considered to be less risky than FBIOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.